Predict your next investment

Corporation
HEALTHCARE | Biotechnology
perkinelmer.com

See what CB Insights has to offer

Investments

5

Portfolio Exits

6

Partners & Customers

10

Service Providers

3

About PerkinElmer

PerkinElmer is a biotechnology company that offers a diagnostics portfolio focused on reproductive health, infectious disease screening, and genomics offerings for oncology and other molecular tests through its wide range of instruments, reagents, assay platforms, and software offerings.

PerkinElmer Headquarter Location

940 Winter St.

Waltham, Massachusetts, 2451,

United States

781-663-6900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PerkinElmer

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find PerkinElmer in 3 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

M

Medical Devices

3,607 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

PerkinElmer Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PerkinElmer Rank

PerkinElmer Investments

5 Investments

PerkinElmer has made 5 investments. Their latest investment was in Caike Bio as part of their Series A - III on July 7, 2021.

CBI Logo

PerkinElmer Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/5/2021

Series A - III

Caike Bio

Yes

4

6/21/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/16/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/1/2005

Seed

Subscribe to see more

$99M

Subscribe to see more

10

10/11/2000

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/5/2021

6/21/2021

12/16/2020

4/1/2005

10/11/2000

Round

Series A - III

Series A

Series A

Seed

Corporate Minority

Company

Caike Bio

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

10

10

10

10

PerkinElmer Portfolio Exits

6 Portfolio Exits

PerkinElmer has 6 portfolio exits. Their latest portfolio exit was PerkinElmer - Phenoptics on October 31, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/31/2018

Divestiture

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/31/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Divestiture

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

PerkinElmer Acquisitions

32 Acquisitions

PerkinElmer acquired 32 companies. Their latest acquisition was BioLegend on July 26, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/26/2021

$991

Acquired

7

6/22/2021

Series D

Acquired

5

5/17/2021

IPO

$991

Acq - Pending

12

5/12/2021

Private Equity

Subscribe to see more

$991

$99M

Subscribe to see more

10

1/7/2021

IPO

Subscribe to see more

$991

$99M

Subscribe to see more

10

Date

7/26/2021

6/22/2021

5/17/2021

5/12/2021

1/7/2021

Investment Stage

Series D

IPO

Private Equity

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

$991

Total Funding

$99M

$99M

Note

Acquired

Acquired

Acq - Pending

Subscribe to see more

Subscribe to see more

Sources

7

5

12

10

10

PerkinElmer Partners & Customers

10 Partners and customers

PerkinElmer has 10 strategic partners and customers. PerkinElmer recently partnered with GENWORKS Health on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/26/2021

Distributor

GENWORKS Health

India

PerkinElmer India Signs Distribution Agreement with GenWorks Health

PerkinElmer Inc. , a global leader committed to innovating for a healthier world , is collaborating with GenWorks Health to be the exclusive distributor of solutions in the PerkinElmer Inc. newborn and prenatal screening portfolio .

2

10/14/2021

Partner

LabCentral

United States

PerkinElmer : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery

WHAT : PerkinElmer , Inc. a global leader committed to innovating for a healthier world , today announced it is collaborating with leading life science incubators LabCentral in Boston , Massachusetts and MBC BioLabs in San Francisco , California to provide innovative , drug discovery technologies , expertise and training to help pharma and biotech start-ups more quickly and accurately identify and accelerate potential clinical trial candidates .

1

9/30/2021

Partner

UPM Biomedicals

Finland

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

2

2/22/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

10/30/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/26/2021

10/14/2021

9/30/2021

2/22/2021

10/30/2020

Type

Distributor

Partner

Partner

Partner

Partner

Business Partner

GENWORKS Health

LabCentral

UPM Biomedicals

Country

India

United States

Finland

Subscribe to see more

Subscribe to see more

News Snippet

PerkinElmer India Signs Distribution Agreement with GenWorks Health

PerkinElmer Inc. , a global leader committed to innovating for a healthier world , is collaborating with GenWorks Health to be the exclusive distributor of solutions in the PerkinElmer Inc. newborn and prenatal screening portfolio .

PerkinElmer : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery

WHAT : PerkinElmer , Inc. a global leader committed to innovating for a healthier world , today announced it is collaborating with leading life science incubators LabCentral in Boston , Massachusetts and MBC BioLabs in San Francisco , California to provide innovative , drug discovery technologies , expertise and training to help pharma and biotech start-ups more quickly and accurately identify and accelerate potential clinical trial candidates .

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

2

10

10

PerkinElmer Service Providers

4 Service Providers

PerkinElmer has 4 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Acq - P2P

Subscribe to see more

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

PerkinElmer Team

22 Team Members

PerkinElmer has 22 team members, including current President, E. Kevin Hrusovsky.

Name

Work History

Title

Status

E. Kevin Hrusovsky

President

Current

Daniel R Marshak

President

Current

Robert A Barrett

Senior Vice President

Current

Gregory L. Summe

Chief Executive Officer

Former

Daniel Chelsky

President

Former

Name

E. Kevin Hrusovsky

Daniel R Marshak

Robert A Barrett

Gregory L. Summe

Daniel Chelsky

Work History

Title

President

President

Senior Vice President

Chief Executive Officer

President

Status

Current

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.